TIVC
Tivic Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Ample Liquidity
Negative Gross Margin
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TIVC
Tivic Health Systems, Inc.
A commercial-phase health technology company that offering non-invasive bioelectronic treatments for inflammation and certain other related conditions
Healthcare Equipment and Supplies
09/22/2016
11/11/2021
NASDAQ Stock Exchange
7
12-31
Common stock
47685 Lakeview Blvd., Fremont, CA 94538
--
Tivic Health Systems, Inc., was incorporated in California on September 22, 2016. Effective June 7, 2021, the Company was re-registered as a Delaware corporation. The company is a health technology company specializing in bioelectronic medicine. The company is a health technology company specializing in bioelectronic medicine. Bioelectronic medicine is a branch of the global neuromodulation market that treats diseases and conditions by modulating electrical signals carried along various neural pathways. This field originates from the neuromodulation industry and has historically relied on implantable devices.
Earnings Call
Company Financials
EPS
TIVC has released its 2025 Q2 earnings. EPS was reported at -2.19, versus the expected 0, missing expectations. The chart below visualizes how TIVC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TIVC has released its 2025 Q3 earnings report, with revenue of 146.00K, reflecting a YoY change of 15.87%, and net profit of -2.60M, showing a YoY change of -81.41%. The Sankey diagram below clearly presents TIVC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


